Your browser doesn't support javascript.
loading
Safety and efficacy of letetresgene autoleucel alone or with pembrolizumab for relapsed/refractory multiple myeloma.
Nishihori, Taiga; Hoffman, James E; Huff, Anne; Kapoor, Gurpreet S; Eleftheriadou, Ioanna; Zajic, Stefan; Urbano, Alisa; Suchindran, Sunil; Chisamore, Michael; D'Souza, Jimson W; Faitg, Thomas; Rapoport, Aaron P.
Affiliation
  • Nishihori T; Moffitt Cancer Center, Tampa, FL.
  • Hoffman JE; Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL.
  • Huff A; GlaxoSmithKline, Collegeville, PA.
  • Kapoor GS; GlaxoSmithKline, Collegeville, PA.
  • Eleftheriadou I; GlaxoSmithKline, Collegeville, PA.
  • Zajic S; GlaxoSmithKline, Collegeville, PA.
  • Urbano A; GlaxoSmithKline, Collegeville, PA.
  • Suchindran S; GlaxoSmithKline, Collegeville, PA.
  • Chisamore M; Merck & Co, Inc, Rahway, NJ.
  • D'Souza JW; GlaxoSmithKline, Collegeville, PA.
  • Faitg T; GlaxoSmithKline, Collegeville, PA.
  • Rapoport AP; University of Maryland Greenebaum Comprehensive Cancer Center and School of Medicine, Baltimore, MD.
Blood Adv ; 7(7): 1168-1177, 2023 04 11.
Article in En | MEDLINE | ID: mdl-36534160
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Esophageal Neoplasms / Esophageal Squamous Cell Carcinoma / Multiple Myeloma Limits: Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Esophageal Neoplasms / Esophageal Squamous Cell Carcinoma / Multiple Myeloma Limits: Humans Language: En Year: 2023 Type: Article